HomeERFO • BIT
add
Laboratorio Farmaceutico Erfo SpA
Previous close
€1.72
Day range
€1.69 - €1.72
Year range
€0.88 - €1.80
Market cap
15.12M EUR
Avg Volume
24.30K
P/E ratio
37.12
Dividend yield
-
Primary exchange
BIT
Market news
The Globe and Mail
18 hours ago
TSX falls the most in six months as gold slides and inflation heats up
1.73%
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.53M | 58.35% |
Operating expense | 635.82K | 29.49% |
Net income | 154.65K | 7.19% |
Net profit margin | 6.11 | -32.26% |
Earnings per share | — | — |
EBITDA | 561.56K | 49.98% |
Effective tax rate | 37.29% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.04M | -31.45% |
Total assets | 12.30M | 16.91% |
Total liabilities | 4.15M | 39.29% |
Total equity | 8.15M | — |
Shares outstanding | 8.52M | — |
Price to book | 1.84 | — |
Return on assets | 7.56% | — |
Return on capital | 9.66% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 154.65K | 7.19% |
Cash from operations | 294.21K | -19.15% |
Cash from investing | -564.87K | -1,340.30% |
Cash from financing | 605.07K | 977.48% |
Net change in cash | 334.41K | -1.78% |
Free cash flow | -789.02K | -414.61% |
About
Founded
2013
Website
Employees
47
